Search results
Medical Oncologist with interests in Thoracic and Hepatobiliary Cancers, Geriatric Oncology and Acute Oncology Service. · Experience: Royal Darwin Hospital · Location: Sydney · 24 connections...
- 24
- Royal Darwin Hospital
- 26
Sep 8, 2020 · Yat-Ming Lau, MBBS Department of Clinical Oncology, Faculty of Medicine, State Key Laboratory in Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China View all articles by this author
- Yat-Ming Lau, Tony S.K. Mok
- 2020
Yat-Ming Lau 1 , Tony S K Mok 1 Affiliation 1 Department of Clinical Oncology, Faculty of Medicine, State Key Laboratory in Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
- Yat-Ming Lau, Tony S.K. Mok
- 2020
Enrique Soto-Perez-de-Celis*, Daneng Li*, Yuan Yuan, Yat Ming Lau, Arti Hurria As the worldwide population ages, oncologists are often required to make difficult and complex decisions regarding the treatment of older people (aged 65 years and older) with cancer.
Yat-Ming Lau's 8 research works with 44 citations and 328 reads, including: Prevalence and prognostic impact of comorbidities and peripheral blood indices in sarcomas.
Articles by Yat Ming Lau on Muck Rack. Find Yat Ming Lau's email address, contact information, LinkedIn, Twitter, other social media and more.
Sep 29, 2018 · Substances. Non-small cell lung cancer (NSCLC) harboring epidermal growth receptor (EGFR) mutation has distinct genomic characteristics. Introduction of systemic treatments that specifically targeted actionable EGFR mutations has changed the therapeutic paradigm in this group of patients. Moreover, newer genera ….